Biomarkers and subclinical atherosclerosis as assessed by vascular ultrasound; and the interplay with clinical risk factors, behavior and psychological determinants. Serial analyses of biomarkers over a time-period of up to 26 years in VIPVIZA
Swedish Heart-Lung Foundation
· Sweden · 15M kr SEK
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.